Nevro Responds to Competitor's Announcement of FDA Approval for Painful Diabetic Neuropathy
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
Source: prnewswire.com